Brief: Zealand Pharma To Use Gefion AI To Accelerate Drug Discovery
Jan 9 (Reuters) - Zealand Pharma A/S ZELA.CO: ENTERS AGREEMENT WITH DCAI TO USE GEFION AI SUPERCOMPUTER TO ACCELERATE DRUG DISCOVERY Source text: (Full Story) Further company coverage: ZELA.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Zealand Pharma A/S
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Zealand Pharma Announces Positive Topline Results From Phase 1 Trial With ZP9830
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Zealand Pharma, Generate Biomedicines Enter Collaboration, License Agreement
Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion (updated)